文献速递胸部肿瘤放疗中枢神经肿瘤放疗姑息放疗与转移瘤

广泛期小细胞肺癌预防性颅脑照射:从过去到免疫治疗时代的持续争议

Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era".
PubMed 文献 · Clin Transl Radiat Oncol · 2026-03-21

本文综述广泛期小细胞肺癌(ES-SCLC)中预防性颅脑照射(PCI)的既往关键研究及免疫化疗时代下的再评价。免疫治疗可能增强全身控制、改善生存并降低脑转移风险,从而引发PCI必要性的讨论。综述同时评估PCI的认知影响与生活质量风险,并探讨MRI监测等替代策略及最可能获益的患者人群。

要点

  • PCI可降低脑转移发生率,免疫治疗前荟萃分析显示可改善总生存。
  • 免疫化疗增强全身控制后,PCI的必要性正被重新评估。
  • 需权衡PCI的认知影响与生活质量风险,并探索MRI监测等替代策略。

核心结论

  • 免疫化疗时代下PCI的角色需重新评估,部分患者可能可省略PCI。
  • PCI仍可降低脑转移发生率,但需权衡认知影响与生活质量风险。

研究设计与样本

  • 本文为综述,审视塑造既往指南的关键研究及当前治疗格局下PCI有效性的认识演变。
  • 综述评估支持与质疑PCI作用的研究,并探讨MRI监测等替代策略。

主要发现

  • PCI已被显示可降低脑转移发生率。
  • 免疫治疗前荟萃分析(Auperin等)显示PCI可改善总生存。
  • 免疫治疗可能增强全身控制、改善生存并降低脑转移风险。
  • PCI存在认知影响与生活质量等长期并发症风险。

临床怎么用

  • 临床需根据患者情况评估PCI获益与风险,识别最可能获益及可省略PCI的人群。
  • 可考虑MRI监测作为PCI的替代策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SCLC (Small Cell Lung Cancer) is categorized into two stages: limited-stage (LS-SCLC), where the cancer is confined to a single radiation field, and extensive-stage, where the disease has spread beyond the chest, potentially including the brain. In managing extensive-stage SCLC (ES-SCLC), preventing brain metastases becomes a crucial goal, as these metastases are a major cause of mortality due to their severe complications. Prophylactic cranial irradiation (PCI) has been shown to reduce the incidence of brain metastases and, according to the pre-immunotherapy meta-analysis by Auperin et al., improve overall survival (OS). With the advent of chemoimmunotherapy in extensive-stage SCLC, the role of PCI is being re-evaluated, as immunotherapy may enhance systemic control, improve survival, and lower the risk of brain metastases, raising questions about the continued necessity of PCI. This review examines key studies that shaped prior guidelines and the evolving understanding of PCI's effectiveness in the current treatment landscape. It evaluates both studies supporting and questioning PCI's role, given the enhanced systemic control with immuno-chemotherapy, while also addressing the risks and long-term complications of PCI, including cognitive impacts and quality of life concerns. Additionally, the review explores alternative strategies, such as MRI surveillance, and identifies which patient populations are most likely to benefit from PCI and in which patients PCI can be omitted.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Najdi T, Richa A, Chamieh M, et al. Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era". Clin Transl Radiat Oncol. 2026. PMID: 41938987. doi:10.1016/j.ctro.2026.101153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。